A Retrospective Study to Evaluate the Clinical Outcome According to Treatment in aHUS Patients in South Korea

97 participants · First posted Jun 6, 2022

Observational Study of Elizaria® in aHUS Patients

50 participants · First posted Feb 11, 2021

Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS

20 participants · First posted Dec 29, 2025

C5 siRNA therapy (IgAN/MG/PNH/aHUS)

Eculizumab(Soliris, Epysqli, Bekemv)

Rx

Haus Bioceuticals Inc

United States

AHS HOSPITAL CORP.

United States

BEIGENE AUS PTY LTD

Australia

Early Platelet Count Changes Predict Ultomiris Response in aHUS Patients

Alexion Launches Interactive Storybook to Help Children Understand Rare Kidney Disease aHUS

FDA Approves Epysqli, an Eculizumab Biosimilar for PNH and aHUS